These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

445 related articles for article (PubMed ID: 20811456)

  • 1. Bacterial charity work leads to population-wide resistance.
    Lee HH; Molla MN; Cantor CR; Collins JJ
    Nature; 2010 Sep; 467(7311):82-5. PubMed ID: 20811456
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Resistance Gene Carriage Predicts Growth of Natural and Clinical
    Allen RC; Angst DC; Hall AR
    Appl Environ Microbiol; 2019 Feb; 85(4):. PubMed ID: 30530714
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nitrofurantoin resistance mechanism and fitness cost in Escherichia coli.
    Sandegren L; Lindqvist A; Kahlmeter G; Andersson DI
    J Antimicrob Chemother; 2008 Sep; 62(3):495-503. PubMed ID: 18544599
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Predictable properties of fitness landscapes induced by adaptational tradeoffs.
    Das SG; Direito SO; Waclaw B; Allen RJ; Krug J
    Elife; 2020 May; 9():. PubMed ID: 32423531
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biological cost of single and multiple norfloxacin resistance mutations in Escherichia coli implicated in urinary tract infections.
    Komp Lindgren P; Marcusson LL; Sandvang D; Frimodt-Møller N; Hughes D
    Antimicrob Agents Chemother; 2005 Jun; 49(6):2343-51. PubMed ID: 15917531
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rapid emergence of high-level tigecycline resistance in Escherichia coli strains harbouring blaNDM-5 in vivo.
    Li X; Mu X; Yang Y; Hua X; Yang Q; Wang N; Du X; Ruan Z; Shen X; Yu Y
    Int J Antimicrob Agents; 2016 Apr; 47(4):324-7. PubMed ID: 26944192
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mechanisms and fitness costs of tigecycline resistance in Escherichia coli.
    Linkevicius M; Sandegren L; Andersson DI
    J Antimicrob Chemother; 2013 Dec; 68(12):2809-19. PubMed ID: 23843301
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fitness cost constrains the spectrum of marR mutations in ciprofloxacin-resistant Escherichia coli.
    Praski Alzrigat L; Huseby DL; Brandis G; Hughes D
    J Antimicrob Chemother; 2017 Nov; 72(11):3016-3024. PubMed ID: 28962020
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cross-resistance to fluoroquinolones in multiple-antibiotic-resistant (Mar) Escherichia coli selected by tetracycline or chloramphenicol: decreased drug accumulation associated with membrane changes in addition to OmpF reduction.
    Cohen SP; McMurry LM; Hooper DC; Wolfson JS; Levy SB
    Antimicrob Agents Chemother; 1989 Aug; 33(8):1318-25. PubMed ID: 2679373
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quantifying the Determinants of Evolutionary Dynamics Leading to Drug Resistance.
    Chevereau G; Dravecká M; Batur T; Guvenek A; Ayhan DH; Toprak E; Bollenbach T
    PLoS Biol; 2015; 13(11):e1002299. PubMed ID: 26581035
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mechanisms involved in the development of resistance to fluoroquinolones in Escherichia coli isolates.
    Tavío MM; Vila J; Ruiz J; Ruiz J; Martín-Sánchez AM; Jiménez de Anta MT
    J Antimicrob Chemother; 1999 Dec; 44(6):735-42. PubMed ID: 10590273
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mutant-prevention concentration and mechanism of resistance in clinical isolates and enrofloxacin/marbofloxacin-selected mutants of Escherichia coli of canine origin.
    Gebru E; Choi MJ; Lee SJ; Damte D; Park SC
    J Med Microbiol; 2011 Oct; 60(Pt 10):1512-1522. PubMed ID: 21596912
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Active efflux of antibiotics as multiple-antibiotic-resistance mechanism in clinical strains of escherichia coli].
    Zhang X; Li J
    Zhonghua Yi Xue Za Zhi; 2000 Aug; 80(8):614-7. PubMed ID: 11798829
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quinolone Resistance Reversion by Targeting the SOS Response.
    Recacha E; Machuca J; Díaz de Alba P; Ramos-Güelfo M; Docobo-Pérez F; Rodriguez-Beltrán J; Blázquez J; Pascual A; Rodríguez-Martínez JM
    mBio; 2017 Oct; 8(5):. PubMed ID: 29018116
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mutational Activation of Antibiotic-Resistant Mechanisms in the Absence of Major Drug Efflux Systems of Escherichia coli.
    Cho H; Misra R
    J Bacteriol; 2021 Jun; 203(14):e0010921. PubMed ID: 33972351
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combined exposure to non-antibiotic pharmaceutics and antibiotics in the gut synergistically promote the development of multi-drug-resistance in
    Shi D; Hao H; Wei Z; Yang D; Yin J; Li H; Chen Z; Yang Z; Chen T; Zhou S; Wu H; Li J; Jin M
    Gut Microbes; 2022; 14(1):2018901. PubMed ID: 35014598
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interspecies signalling: Pseudomonas putida efflux pump TtgGHI is activated by indole to increase antibiotic resistance.
    Molina-Santiago C; Daddaoua A; Fillet S; Duque E; Ramos JL
    Environ Microbiol; 2014 May; 16(5):1267-81. PubMed ID: 24373097
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quantitative contribution of efflux to multi-drug resistance of clinical Escherichia coli and Pseudomonas aeruginosa strains.
    Cunrath O; Meinel DM; Maturana P; Fanous J; Buyck JM; Saint Auguste P; Seth-Smith HMB; Körner J; Dehio C; Trebosc V; Kemmer C; Neher R; Egli A; Bumann D
    EBioMedicine; 2019 Mar; 41():479-487. PubMed ID: 30852163
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Whole-Genome Sequencing and Genetic Analysis Reveal Novel Stress Responses to Individual Constituents of Essential Oils in Escherichia coli.
    Chueca B; Renzoni A; Berdejo D; Pagán R; Kelley WL; García-Gonzalo D
    Appl Environ Microbiol; 2018 Apr; 84(7):. PubMed ID: 29374037
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nonclonal Emergence of Colistin Resistance Associated with Mutations in the BasRS Two-Component System in Escherichia coli Bloodstream Isolates.
    Janssen AB; Bartholomew TL; Marciszewska NP; Bonten MJM; Willems RJL; Bengoechea JA; van Schaik W
    mSphere; 2020 Mar; 5(2):. PubMed ID: 32161146
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.